One-year results from the PINNACLE FLX trial show Boston Scientific Corp.’s WATCHMAN FLX system can safely and effectively close the left-atrial appendage closure device in patients with non-valvular atrial fibrillation.
Shephal Doshi of the Pacific Heart Institute in Santa Monica, CA, presented the 12-month follow-up data from the trial during...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?